Improve quality of life and contribute to human welfare by developing next-generation biopharmaceuticals
Development of next-generation biological drugs
  • Platform technology to lead the next-generation of bioconjugate drugs
  • Applicable to various protein/peptide drugs
  • Applicable to antibodies, chemically synthesized drugs
Biological drugs for unmet medical needs
  • Focused on existing drugs that are ineffective and with high side effects
  • Technology to minimize side effects such as immunogenicity
  • Development of orphan drugs with unmet medical demand
Innovative business model
  • Consulting from the initial stage for global technology transfer
  • Collaborate with professional consulting organizations
  • Expansion of joint research/global joint clinical trials